Abstract:figure legend Methylglyoxal, a toxic by‐product of glycolysis, is sufficiently detoxified in healthy conditions. In diabetes, however, the formation is increased due to increase in glycolysis and its detoxification is reduced, leading to an increase in protein modifications, known as advanced glycation endproducts (AGEs). In mice, MGO‐derived AGEs can lead to a reduction of the neurovascular coupling response and induce mild cognitive impairment. We found that genetic overexpression of human Glyoxalase 1 (huGlo1+/−) increases the MGO detoxification and reduces AGE formation, preventing the negative effect on the brain and brain microvasculature. Diabetes is associated with cognitive impairment, but the underlying mechanism remains unclear. Methylglyoxal (MGO), a precursor to advanced glycation endproducts (AGEs), is elevated in diabetes and linked to microvascular dysfunction. In this study, overexpression of the MGO‐detoxifying enzyme glyoxalase 1 (Glo1) was used in a mouse model of diabetes to explore whether MGO accumulation in diabetes causes cognitive impairment. Diabetes was induced with streptozotocin. Fasting blood glucose, cognitive function, cerebral blood flow, neurovascular coupling (NVC), Glo1 activity, MGO and AGEs were assessed. In diabetes, MGO‐derived hydroimidazolone‐1 increased in the cortex, and was decreased in Glo1‐overexpressing mice compared to controls. Visuospatial memory was decreased in diabetes, but not in Glo1/diabetes. NVC response time was slightly increased in diabetes, and normalised in the Glo1‐overexpressing group. No impact of diabetes or Glo1 overexpression on blood–brain barrier integrity or vascular density was observed. Diabetes induced a mild visuospatial memory impairment and slightly reduced NVC response speed and these effects were mitigated by Glo1. This study shows a link between MGO‐related AGE accumulation and cerebrovascular/cognitive functions in diabetes. Modulation of the MGO–Glo1 pathway may be a novel intervention strategy in patients with diabetes who have cerebrovascular complications. Key points Diabetes is associated with an increased risk of stroke, cognitive decline, depression and Alzheimer's disease, but the underlying mechanism remains unclear. Methylglyoxal (MGO), a highly reactive by‐product of glycolysis, plays an important role in the development of diabetes‐associated microvascular dysfunction in the periphery and is detoxified by the enzyme glyoxalase 1. Diabetes reduced visuospatial memory in mice and slowed the neurovascular coupling response speed, which was improved by overexpression of glyoxalase 1. MGO formation and MGO‐derived advanced glycation endproduct (AGE) accumulation in the brain of diabetic mice are associated with a slight reduction in neurovascular coupling and mild cognitive impairment. The endogenous formation of MGO, and the accumulation of MGO‐derived AGEs, might be a potential target in reducing the risk of vascular cognitive impairment in people with diabetes.

GLT-1 downregulation in hippocampal astrocytes induced by type 2 diabetes contributes to postoperative cognitive dysfunction in adult mice

Metabonomic profiles delineate potential role of glutamate-glutamine cycle in db/db mice with diabetes-associated cognitive decline

Characteristic Metabolic Alterations Identified in Primary Neurons under High Glucose Exposure

Neuronal Hyperactivity in the Hippocampus during the Early Stage of Streptozotocin-Induced Type 1 Diabetes in Mice

Chronic hyperglycemia induces tau hyperphosphorylation by downregulating OGT-involved O-GlcNAcylation in vivo and in vitro.

Cognitive decline in type 2 diabetic db/db mice may be associated with brain region-specific metabolic disorders.

Aged hippocampal single‐cell atlas screening unveils disrupted neuroglial system in postoperative cognitive impairment

Glucose Fluctuation Inhibits Nrf2 Signaling Pathway in Hippocampal Tissues and Exacerbates Cognitive Impairment in Streptozotocin-Induced Diabetic Rats

Astrocytic GDNF Ameliorates Anesthesia and Surgery-induced Cognitive Impairment by Promoting Hippocampal Synaptic Plasticity in Aged Mice

Impaired synaptic plasticity and decreased glutamatergic neuron excitability induced by SIRT1/BDNF downregulation in the hippocampal CA1 region are involved in postoperative cognitive dysfunction

Cognitive Deficits and Alzheimer-like Neuropathological Impairments During Adolescence in a Rat Model of Type 2 Diabetes Mellitus

Activation of astrocyte Gq pathway in hippocampal CA1 region attenuates anesthesia/surgery induced cognitive dysfunction in aged mice

Recurrent non-severe hypoglycemia aggravates cognitive decline in diabetes and induces mitochondrial dysfunction in cultured astrocytes

Glyoxalase 1 overexpression improves neurovascular coupling and limits development of mild cognitive impairment in a mouse model of type 1 diabetes

Enhancement of LPS-Induced Microglial Inflammation Response via TLR4 Under High Glucose Conditions

mTOR-mediated autophagy in the hippocampus is involved in perioperative neurocognitive disorders in diabetic rats

AD-Like Neuropsychiatric Dysfunction in a Mice Model Induced by a Combination of High-Fat Diet and Intraperitoneal Injection of Streptozotocin

Diabetes Mellitus-Related Neurobehavioral Deficits in Mice Are Associated with Oligodendrocyte Precursor Cell Dysfunction

NADPH Oxidase 2-Derived Reactive Oxygen Species in the Hippocampus Might Contribute to Microglial Activation in Postoperative Cognitive Dysfunction in Aged Mice.

The Dysfunction of Mgluriis is Involved in the Disorder of Hippocampal Neural Network in Diabetic Mice Model.

Reprogramming astrocytic NDRG2/NF-κB/C3 signaling restores the diabetes-associated cognitive dysfunction